Abiopharma

New Form 4 - Tarsus Pharmaceuticals, Inc. Filed: 2025-06-16 AccNo: 0001819790-25-000088 Size: 12 KB

New Form 144 - Evolus, Inc. Filed: 2025-06-16 AccNo: 0001950047-25-004315 Size: 11 KB

New Form 4 - TEVA PHARMACEUTICAL INDUSTRIES LTD Filed: 2025-06-16 AccNo: 0000950170-25-086697 Size: 5 KB

New Form 4 - Mineralys Therapeutics, Inc. Filed: 2025-06-16 AccNo: 0001933414-25-000067 Size: 8 KB

New Form 144 - DEXCOM INC Filed: 2025-06-16 AccNo: 0001969223-25-000433 Size: 4 KB

New Form 144 - GILEAD SCIENCES, INC. Filed: 2025-06-16 AccNo: 0001950047-25-004309 Size: 12 KB

New Form 8-K - Longeveron Inc. Filed: 2025-06-16 AccNo: 0001213900-25-054755 Size: 203 KB Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits

New Form SCHEDULE 13D/A - CureVac N.V. Filed: 2025-06-16 AccNo: 0001213900-25-054753 Size: 157 KB

New Form 4 - Zomedica Corp. Filed: 2025-06-16 AccNo: 0001654954-25-007004 Size: 5 KB

RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Project Hail Mary Movie Update: Everything We Know So Far

New Form 144 - MESA LABORATORIES INC /CO/ Filed: 2025-06-16 AccNo: 0001959173-25-004118 Size: 4 KB

New Form 144 - MESA LABORATORIES INC /CO/ Filed: 2025-06-16 AccNo: 0001959173-25-004117 Size: 5 KB

New Form 144 - MESA LABORATORIES INC /CO/ Filed: 2025-06-16 AccNo: 0001959173-25-004114 Size: 4 KB

New Form 4 - AN2 Therapeutics, Inc. Filed: 2025-06-16 AccNo: 0001373604-25-000090 Size: 5 KB